Every live tender notice from Contracts Finder, Find a Tender and TED — refreshed hourly, every record linking back to source.
This contract opportunity involves establishing non-exclusive discount agreements for finished pharmaceuticals with various active ingredients or combinations of active ingredients under an 'Open-House Model' as per § 130a Abs. 8 SGB V. Suppliers can join or sign contracts at any time under the same
The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the pharmaceutical substances Dolutegravir and Rilpivirine, classified under ATC J05AR21. This agreement will be effective from July 1, 2025, to June 30, 2027. The contract is part of a framework that allows
